A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds
NCT06018987
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Nasolabial Folds
Interventions
OTHER:
No-Treatment Control
DEVICE:
HAC 20L
Sponsor
AbbVie